{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "3492eee5-235e-47a7-af02-4c825a78b6df",
   "metadata": {},
   "outputs": [],
   "source": [
    "from retraction_audit.audit import RetractionLookup\n",
    "import os\n",
    "\n",
    "os.environ[\"RETRACTION_WATCH_EMAIL\"] = \"james.sharpsteen@gmail.com\"\n",
    "os.environ[\"NCBI_AUTH_EMAIL\"] = \"james.sharpsteen@gmail.com\"\n",
    "\n",
    "lookup = RetractionLookup(True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "50fcb116-34fc-4743-955f-58d78b7ef9d9",
   "metadata": {},
   "outputs": [],
   "source": [
    "from wags_tails import CustomData\n",
    "from wags_tails.utils.downloads import handle_zip, download_http\n",
    "from wags_tails.utils.versioning import DATE_VERSION_PATTERN\n",
    "from datetime import datetime, timezone\n",
    "\n",
    "def _latest_version_cb() -> str:\n",
    "    return datetime.now(tz=timezone.utc).strftime(DATE_VERSION_PATTERN)\n",
    "\n",
    "def _download_cb(version, outfile_path) -> None:\n",
    "        tqdm_params = {\n",
    "            \"disable\": False,\n",
    "            \"unit\": \"B\",\n",
    "            \"ncols\": 80,\n",
    "            \"unit_divisor\": 1024,\n",
    "            \"unit_scale\": True,\n",
    "        }\n",
    "        download_http(\n",
    "            \"https://pmkb.weill.cornell.edu/therapies/download.csv\",\n",
    "            outfile_path,\n",
    "            tqdm_params=tqdm_params,\n",
    "        )\n",
    "\n",
    "data_fetcher = CustomData(\n",
    "    \"pmkb\",\n",
    "    \"csv\",\n",
    "    _latest_version_cb,\n",
    "    _download_cb,\n",
    ")\n",
    "try:\n",
    "    pmkb = data_fetcher.get_latest()\n",
    "except:  # website isn't always up\n",
    "    pmkb = data_fetcher.get_latest(from_local=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "93f76c5c-7d62-490e-8c34-9dd234fd1113",
   "metadata": {},
   "outputs": [],
   "source": [
    "import polars as pl\n",
    "\n",
    "df = pl.read_csv(pmkb[0])\n",
    "unique_cites = set()\n",
    "for row in df[\"Citations\"].unique():\n",
    "    for cite in row.split(\"|\"):\n",
    "        unique_cites.add(cite)\n",
    "len(unique_cites)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "9ce8157b-403e-48b7-91f5-5c54559d46bd",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Cbioportal.org\n",
      "10.1158/2159-8290\n",
      "Kato H, Kato S, Kumabe T, Sonoda Y, Yoshimoto T, Kato S, Han SY, Suzuki T,\n",
      "Kieran MW Targeted treatment for sonic hedgehog-dependent medulloblastoma. Neuro Oncol 2014;16(8):1037-47\n",
      "Schittenhelm J Recent advances in subtyping tumors of the central nervous system using molecular data. Expert Rev Mol Diagn 2017;17(1):83-94\n",
      "Neklason et al. BMC Cancer 2011, 11:424 Activating mutation in MET oncogene in familial colorectal cancer\n",
      "Vellano CP, Schultz N, Karchin R, Ding L, Lu Y, Cheung LWT, Chen K, Shaw KR,\n",
      "Bladder cancer (TCGA, 2017)\n",
      "23689514\n",
      "Spaggiari L, Mazzarol G, Viale G, Pece S, Di Fiore PP. Alterations of the Notch\n",
      "Wong H, et al. Molecular targeted therapies in advanced gastric cancer: does tumor histology matter? Therap Adv Gastroenterol 2013;6(1):15-31\n",
      "http://omim.org/entry/311770\n",
      "induced epithelial-mesenchymal transition and cancer stem cell-like characteristics in\n",
      "VH, Tran R, Soewito S, Minussi DC, Moreno D, Kong K, Dogruluk T, Lu H, Gao J,\n",
      "OncoKB: https://oncokb.org/gene/SMARCB1/R377H\n",
      "Krasinskas AM EGFR Signaling in Colorectal Carcinoma. Patholog Res Int 2011;2011():932932\n",
      "OncoKB http://oncokb.org/gene/PTEN/G129R\n",
      "Afatinib\n",
      "Ferrara N, Hillan KJ, Gerber HP, Novotny W. Discovery and development of\n",
      "Aydin et al FBXW7 Mutations in Melanoma and a New Therapeutic Paradigm. JNCI J\n",
      "Yip L Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy. J Surg Oncol 2015;111(1):43-50\n",
      "K111N\n",
      "JM, Greig MJ, He YA, Jacques SL, Lunney EA, McTigue M, Molina D, Quenzer T, Wells\n",
      "Cancer Genome Atlas Research Network Integrated genomic characterization of papillary thyroid carcinoma. Cell 2014;159(3):676-90\n",
      "Skin Cutaneous Melanoma (TCGA, PanCancer Atlas)\n",
      "Uniprot.org\n",
      "Scott LM The JAK2 exon 12 mutations: a comprehensive review. Am J Hematol 2011;86(8):668-76\n",
      "Gajiwala KS, Wu JC, Christensen J, Deshmukh GD, Diehl W, DiNitto JP, English\n",
      "ClinicalTrials.gov\n",
      "Giordano SH, Temin S, Kirshner JJ, Chandarlapaty S, Crews JR, Davidson NE,\n",
      "https://oncokb.org/#/gene/PTPN11/alteration/E76K\n",
      "Raut CP, Morgan JA, Ashley SW. Current issues in gastrointestinal stromal tumors: incidence,\n",
      "Cox AD, et al. Drugging the undruggable RAS: Mission possible? Nat Rev Drug Discov 2014;13(11):828-51\n",
      "NCCN Guideline Version 2.2016 Breast Cancer\n",
      "Westin G Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours. J Intern Med 2016;280(6):551-558\n",
      "Zhang T, Penicud K, Bruhn C, Loizou JI, Kanu N, Wang ZQ, Behrens A.\n",
      "Comprehensive molecular characterization of human colon and rectal cancer. Cancer Genome Atlas Network 2012 Nature;487(7407):330-7\n",
      "Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein\n",
      "Wilhelm SM, et al. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases\n",
      "Cancer Genome Atlas Network Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 2015;517(7536):576-82\n",
      "Cancer Genome Atlas Research Network Comprehensive molecular profiling of lung adenocarcinoma. Nature 2014;511(7511):543-50\n",
      "Krishnaswamy et al Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer.Clin Cancer Res 2009;15(18) September 15, 2009\n",
      "Nikiforov YE Molecular analysis of thyroid tumors. Mod Pathol 2011;24 Suppl 2():S34-43\n",
      "16843266\n",
      "Ng PK, Li J, Jeong KJ, Shao S, Chen H, Tsang YH, Sengupta S, Wang Z, Bhavana\n",
      "Davies MA Regulation, role, and targeting of Akt in cancer. J Clin Oncol 2011;29(35):4715-7\n",
      "Li YY, Hanna GJ, Laga AC, Haddad RI, Lorch JH, Hammerman PS. Genomic analysis\n",
      "Bladder Cancer (TCGA, 2017)\n",
      "cbioportal.org\n",
      "Gymnopoulos M, Elsliger MA, Vogt PK. Rare cancer-specific mutations in PIK3CA\n",
      "Pirker R Third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer. Curr Opin Oncol 2016;28(2):115-21\n",
      "Volckmar AL, Leichsenring J, Flechtenmacher C, Pfarr N, Siebolts U, Kirchner\n",
      "Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi. Bender RP et a 2013 Modern pathology : an official journal of the United States and Canadian\n",
      "Roskoski R Jr The role of small molecule Kit protein-tyrosine kinase inhibitors in the treatment of neoplastic disorders. Pharmacol Res 2018;133():35-52\n",
      "Bader AG, Kang S, Zhao L, Vogt PK. Oncogenic PI3K deregulates transcription\n",
      "Cancer Genome Atlas Research Network Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013;499(7456):43-9\n",
      "Tokheim C, Zhou DC, Johnson AM, Zeng J, Ip CKM, Ju Z, Wester M, Yu S, Li Y,\n",
      "Qu CK The SHP-2 tyrosine phosphatase: signaling mechanisms and biological functions. Cell Res 2000;10(4):279-88\n",
      "AACR, Cancer Res: April 2016; Volume 57, Abstract #2644\n",
      "Marlton P The many facets of WT1 in acute myeloid leukemia: clarity remains elusive. Leuk Lymphoma 2014;55(2):235-7\n",
      "Head and Neck Squamous Cell Carcinoma (TCGA, Nature 2015)\n",
      "Moasser MM. The oncogene HER2: its signaling and transforming functions and\n",
      "McCoy KL, et al. The clinical importance of parathyroid atypia: is long-term surveillance necessary? Surgery 2015;158(4):929-35; discussion 935-6\n",
      "Hartmann et al PIK3CA mutations in glioblastoma multiforme.Acta Neuropathol (2005) 109: 639–642\n",
      "Stewart DJ Wnt signaling pathway in non-small cell lung cancer. J Natl Cancer Inst 2014;106(1):djt356\n",
      "Genome Atlas Network 2012 Nature; 487(7407):330-7\n",
      "von Mehren M Beyond imatinib: second generation c-KIT inhibitors for the management of gastrointestinal stromal tumors. Clin Colorectal Cancer 2006;6 Suppl 1():S30-4\n",
      "Sudhindra A, et al. FLT3 inhibitors in AML: are we there yet? Curr Hematol Malig Rep 2014;9(2):174-85\n",
      "Sakai K, Aoki S, Matsumoto K. Hepatocyte growth factor and Met in drug\n",
      "Cancer Genome Atlas Research Network The Molecular Taxonomy of Primary Prostate Cancer. Cell 2015;163(4):1011-25\n",
      "UniProt.org\n",
      "O'Neil J, et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to\n",
      "Wang Y, Liu Y, Lu J, Zhang P, Wang Y, et al. (2013) Rapamycin inhibits FBXW7 loss-\n",
      "Springall F, et al. c-fms point mutations in acute myeloid leukemia: fact or fiction? Leukemia 1993;7(7):978-85\n",
      "Greulich H, Kaplan B, Mertins P, Chen TH, Tanaka KE, Yun CH, Zhang X, Lee SH,\n",
      "Kan Z, Zheng H, Liu X, Li S, Barber TD, Gong Z, Gao H, Hao K, Willard MD, Xu\n",
      "Capovilla M [Cellular and molecular mechanisms of carcinogenic side effects and resistance to BRAF inhibitors in metastatic melanoma with BRAFV600 mutation: state of the knowledge]. Ann Pathol 2013;33(6):375-85\n",
      "Vinayanuwattikun C, Le Calvez-Kelm F, Abedi-Ardekani B, Zaridze D, Mukeria A,\n",
      "27962476\n",
      "Shibuya M. Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various\n",
      "Gefitinib\n",
      "Odze RD and Goldblum JR. Odze and Goldblum Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas, 3rd Edition\n",
      "Nikiforov YE Molecular diagnostics of thyroid tumors. Arch Pathol Lab Med 2011;135(5):569-77\n",
      "Erlotinib\n",
      "Westhoff B, Colaluca IN, D'Ario G, Donzelli M, Tosoni D, Volorio S, Pelosi G,\n",
      "Jardim et al 2014. FBXW7 Mutations in Patients with Advanced Cancers: Clinical and\n",
      "Burke JE, Perisic O, Masson GR, Vadas O, Williams RL. Oncogenic mutations\n",
      "Mossé YP Anaplastic Lymphoma Kinase as a Cancer Target in Pediatric Malignancies. Clin Cancer Res 2016;22(3):546-52\n",
      "McCabe MJ Use of histoacryl tissue adhesive to manage an avulsed tooth. BMJ 1990;301(6742):20-1\n",
      "Song Y, et al. Identification of genomic alterations in oesophageal squamous\n",
      "15;21(6):1447-56.\n",
      "Perez-Soler R Phase II clinical trial data with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib (OSI-774) in non-small-cell lung cancer. Clin Lung Cancer 2004;6 Suppl 1():S20-3\n",
      "Glioblastoma Multiforme (TCGA, PanCancer Atlas) cbioportal.org\n",
      "McIlwain H Biochemistry and neurochemistry in the 1800s: their origins in comparative animal chemistry. Essays Biochem 1990;25():197-224\n",
      "Cremona et al ATM signalling and cancer. Oncogene (2014) 33, 3351–3360\n",
      "Rothschild SI Targeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALK. Cancers (Basel) 2015;7(2):930-49\n",
      "Detection and Therapeutic Implications of c-Met Mutations in Small Cell Lung Cancer and Neuroendocrine Tumors. Voortman J et al 2012 Current pharmaceutical design\n",
      "NGS sequencing of 240 NSCLC cases treated at MSKCC with anti-PD-(L)1 based therapy using the MSK-IMPACT assay.\n",
      "Chen CY, Chen YY, Hsieh MS, Ho CC, Chen KY, Shih JY, Yu CJ. Expression of\n",
      "Lee S, Lee J, Sim SH, Lee Y, Moon KC, Lee C, Park WY, Kim NK, Lee SH, Lee H.\n",
      "PA, Yu X, Zhang Y, Zou A, Emmett MR, Marshall AG, Zhang HM, Demetri GD. KIT\n",
      "Berlin J Beyond exon 2--the developing story of RAS mutations in colorectal cancer. N Engl J Med 2013;369(11):1059-60\n",
      "Blood 2015 126:1730;\n",
      "Aydin et al FBXW7 Mutations in Melanoma and a New Therapeutic Paradigm. JNCI J Natl Cancer Inst (2014) 106\n",
      "Sanchez-Cespedes M A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene 2007;26(57):7825-32\n",
      "Zou B, Zhou XL, Lai SQ, Liu JC. Notch signaling and non-small cell lung\n",
      "Choi M, Kipps T, Kurzrock R. ATM Mutations in Cancer: Therapeutic\n",
      "Arcila et al EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics. Mol Cancer Ther; 12(2); 220–9\n",
      "Shibata H, Kanamaru R, Ishioka C. Functional evaluation of p53 and PTEN gene\n",
      "Schröder LB, et al. CDK4/6 Inhibitor PD0332991 in Glioblastoma Treatment: Does It Have a Future? Front Oncol 2015;5():259\n",
      "Flaherty KT BRAF inhibitors and melanoma. Cancer J 2011;17(6):505-11\n",
      "Sidaway P Prostate cancer: Wnt signalling induces resistance. Nat Rev Urol 2015;12(11):597\n",
      "Meric-Bernstam F, Scott KL, Yi S, Sahni N, Liang H, Mills GB. Systematic\n",
      "Verstovsek S Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression. Eur J Haematol 2013;90(2):89-98\n",
      "Xing M Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer 2013;13(3):184-99\n",
      "Cancer Genome Atlas Research Network. Comprehensive molecular profiling of\n",
      "Cancer Genome Atlas Network Comprehensive molecular portraits of human breast tumours. Nature 2012;490(7418):61-70\n",
      "16;117(2):239-51.\n",
      "Bachmann W [Medical education--reform of the \"reform\"]. Fortschr Med 1980;98(28):1039-40\n",
      "Notch Gene and Its Impact on Survival of Patients with Resectable Non-small Cell\n",
      "Brugarolas J Molecular genetics of clear-cell renal cell carcinoma. J Clin Oncol 2014;32(18):1968-76\n",
      "Cancer Genome Atlas Research Network, Kandoth C, Schultz N, Cherniack AD,\n",
      "molecular biology, and contemporary treatment of localized and advanced disease. Curr Opin\n",
      "Comprehensive molecular characterization of human colon and rectal cancer. Cancer\n",
      "Cancer Genome Atlas Research Network Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014;513(7517):202-9\n",
      "Natl Cancer Inst (2014) 106\n"
     ]
    }
   ],
   "source": [
    "for cite in unique_cites:\n",
    "    match = re.match(pattern, cite)\n",
    "    if not match:\n",
    "        print(cite)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7d80c4a1-4001-46ac-af85-b24bbf2d735a",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  2%|█▍                                                                                       | 26/1562 [00:08<09:00,  2.84it/s]Got unexpected number of PMID matches for Epidermal growth factor receptor mutation in gastric cancer by Liu: 12\n",
      "  2%|█▋                                                                                       | 29/1562 [00:09<11:46,  2.17it/s]Got unexpected number of PMID matches for Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts by Li: 16\n",
      "  3%|██▌                                                                                      | 44/1562 [00:12<04:40,  5.41it/s]Got unexpected number of PMID matches for Enasidenib in mutant &lt;i&gt;IDH2&lt;/i&gt; relapsed or refractory acute myeloid leukemia by Stein: 7\n",
      "  4%|███▋                                                                                     | 65/1562 [00:16<05:14,  4.76it/s]Got unexpected number of PMID matches for Review by Kim: 20\n",
      "  7%|█████▊                                                                                  | 103/1562 [00:25<05:42,  4.26it/s]Got unexpected number of PMID matches for 2015 by Martin: 20\n",
      "  7%|██████▌                                                                                 | 116/1562 [00:27<06:06,  3.95it/s]Got unexpected number of PMID matches for Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas by Arcila: 2\n",
      " 10%|████████▉                                                                               | 158/1562 [00:38<06:49,  3.43it/s]Got unexpected number of PMID matches for The FGF/FGFR axis as a therapeutic target in breast cancer by Brady: 2\n",
      " 10%|█████████                                                                               | 161/1562 [00:39<06:22,  3.66it/s]Got unexpected number of PMID matches for Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline by Giordano: 2\n",
      " 10%|█████████▏                                                                              | 162/1562 [00:40<07:38,  3.05it/s]Got unexpected number of PMID matches for Pathology by Liu: 20\n",
      " 11%|█████████▋                                                                              | 171/1562 [00:42<06:06,  3.79it/s]Got unexpected number of PMID matches for Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification by Guo: 20\n",
      " 12%|██████████▏                                                                             | 180/1562 [00:43<03:53,  5.91it/s]Got unexpected number of PMID matches for CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons by Tefferi: 4\n",
      " 12%|██████████▎                                                                             | 183/1562 [00:44<03:55,  5.84it/s]Got unexpected number of PMID matches for CDKN2A germline mutations in familial pancreatic cancer by Bartsch: 6\n",
      " 15%|█████████████▍                                                                          | 238/1562 [00:54<02:51,  7.72it/s]Got unexpected number of PMID matches for Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML by Dicker: 2\n",
      " 16%|██████████████                                                                          | 250/1562 [00:56<04:11,  5.22it/s]Got unexpected number of PMID matches for BRAF mutation in metastatic colorectal cancer by Tol: 3\n",
      " 17%|███████████████▏                                                                        | 270/1562 [01:00<04:03,  5.31it/s]Got unexpected number of PMID matches for A systematic review of dual targeting in HER2-positive breast cancer by Kümler: 2\n",
      " 19%|████████████████▌                                                                       | 293/1562 [01:05<03:51,  5.49it/s]Got unexpected number of PMID matches for JAK1 mutations are not frequent events in adult T-ALL: a GRAALL study by Asnafi: 6\n",
      " 19%|████████████████▉                                                                       | 301/1562 [01:09<08:15,  2.54it/s]Got unexpected number of PMID matches for Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma by Giannakis: 2\n",
      " 20%|█████████████████▏                                                                      | 306/1562 [01:10<07:09,  2.92it/s]Got unexpected number of PMID matches for Combined vemurafenib and cobimetinib in BRAF-mutated melanoma by Larkin: 2\n",
      " 22%|██████████████████▉                                                                     | 337/1562 [01:18<04:53,  4.17it/s]Got unexpected number of PMID matches for 2015 by Martin: 20\n",
      " 22%|███████████████████▍                                                                    | 346/1562 [01:20<04:29,  4.51it/s]Got unexpected number of PMID matches for CD79B and MYD88 mutations in diffuse large B-cell lymphoma by Kim: 6\n",
      " 23%|███████████████████▊                                                                    | 352/1562 [01:24<09:13,  2.18it/s]Got unexpected number of PMID matches for Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells by Dolatshad: 2\n",
      " 23%|████████████████████▎                                                                   | 361/1562 [01:25<04:24,  4.53it/s]Got unexpected number of PMID matches for J by Eisenhardt: 20\n",
      " 24%|████████████████████▊                                                                   | 369/1562 [01:26<03:29,  5.69it/s]"
     ]
    }
   ],
   "source": [
    "%%capture --no-stderr\n",
    "\n",
    "from retraction_audit.citation_tools import SqlitePmidCache, get_pmid_from_author_title\n",
    "from pathlib import Path\n",
    "from tqdm import tqdm\n",
    "import re\n",
    "\n",
    "pmid_cache = SqlitePmidCache(Path(\"pmid_cache.db\"))\n",
    "pattern = r\"(.*)\\.[ ]?(.*)\\..*\"\n",
    "\n",
    "pmids = []\n",
    "for cite in tqdm(unique_cites):\n",
    "    match = re.match(pattern, cite)\n",
    "    if not match:\n",
    "        continue\n",
    "    author = match.groups()[0].split(\" \")[0]\n",
    "    title = match.groups()[1]\n",
    "    try:\n",
    "        pmid = get_pmid_from_author_title(author, title, pmid_cache)\n",
    "    except:\n",
    "        continue\n",
    "    pmids.append(pmid)\n",
    "print(len(pmids))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "96cf800d-5e63-41e1-ae50-483815314b20",
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'pmids' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[2], line 2\u001b[0m\n\u001b[1;32m      1\u001b[0m retracted_ev \u001b[38;5;241m=\u001b[39m []\n\u001b[0;32m----> 2\u001b[0m \u001b[38;5;28;01mfor\u001b[39;00m pmid \u001b[38;5;129;01min\u001b[39;00m \u001b[43mpmids\u001b[49m:\n\u001b[1;32m      3\u001b[0m     retraction_record \u001b[38;5;241m=\u001b[39m lookup\u001b[38;5;241m.\u001b[39mget_retraction_by_pmid(\u001b[38;5;28mstr\u001b[39m(pmid))\n\u001b[1;32m      4\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m retraction_record:\n",
      "\u001b[0;31mNameError\u001b[0m: name 'pmids' is not defined"
     ]
    }
   ],
   "source": [
    "retracted_ev = []\n",
    "for pmid in pmids:\n",
    "    retraction_record = lookup.get_retraction_by_pmid(str(pmid))\n",
    "    if retraction_record:\n",
    "        retracted_ev.append(retraction_record)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "c6efd924-982a-418e-bfa0-de6fcb6f1d62",
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'retracted_ev' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[1], line 1\u001b[0m\n\u001b[0;32m----> 1\u001b[0m \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;28mlen\u001b[39m(\u001b[43mretracted_ev\u001b[49m))\n\u001b[1;32m      2\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01mtools\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m store_results\n\u001b[1;32m      3\u001b[0m store_results(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mPMKB\u001b[39m\u001b[38;5;124m\"\u001b[39m, \u001b[38;5;28mlen\u001b[39m(retracted_ev), retracted_ev, \u001b[38;5;28mlen\u001b[39m(unique_cites))\n",
      "\u001b[0;31mNameError\u001b[0m: name 'retracted_ev' is not defined"
     ]
    }
   ],
   "source": [
    "print(len(retracted_ev))\n",
    "from tools import store_results\n",
    "store_results(\"PMKB\", len(retracted_ev), retracted_ev, len(unique_cites))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "49b2ff1a-db69-4845-b2f7-1fc7c51f959f",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "retraction",
   "language": "python",
   "name": "retraction"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
